France· FR:64902013
GEL LARMES, gel ophtalmique
A medicinal product containing carbomère 974p, registered in France by THEA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CARBOMÈRE 974P
- Manufacturer
- THEA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009331948191 tube(s) polyéthylène aluminium de 10 g avec canule(s)EUR 2.99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carbomère 974p in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAaCarb Carbomer 0.2% eye gelTriOn Pharma Ltd
- SpainLACRYVISC 3 mg/g GEL OFTALMICOAlcon Healthcare S.A.
- PolandOftagelSanten Oy
- GermanyCarbomer EdoDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- NetherlandsCarbomeer Medcor één dosis ooggel 2 mg/gMedcor Pharmaceuticals B.V.
- IrelandGeltears 0.2 % w/w carbomer eye gelBausch + Lomb Ireland Limited
- IcelandOftagelSanten Oy*
- FinlandLiposicDr. Gerhard Mann, Chem.-pharm. Fabrik GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Carbomer Agepha
- Belgium · Liposic
- Germany · Carbomer Edo, Liposic
- Denmark · Viscotears
- Spain · Lipolasic
- Finland · Viscotears
- United Kingdom (Northern Ireland) · Viscotears, Viscotears Single Dose Unit
- Greece · Liposic, Viscoter
- Ireland · Geltears, Liposic
- Iceland · Vidisic
- Italy · Lipovisc
- Luxembourg · Vidisic Edo, Vidisic®
- Netherlands · Liposic, Vidisic Carbogel
- Norway · Viscotears
- Poland · Vidisic
- Portugal · Liposic
- Sweden · Viscotears
- Slovakia · Vidisic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7f9dcbe1-dc86-450e-a905-b392cde7eeba GET /v1/drugs/7f9dcbe1-dc86-450e-a905-b392cde7eeba?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64902013",
"date_amm": "1989-06-15",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CARBOMÈRE 974P",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gel",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about carbomère 974p.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.